Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Urowitz

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Rheumatology. Supplement|January 1, 1977
HLA antigens in osteitis condensans ilii and ankylosing spondylitisD P Singal, P de Bosset, D A Gordon, et al.
Clinical and Experimental Rheumatology|July 28, 2010
Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosusZ Touma, D D Gladman, D Tulloch-Reid, et al.
The Journal of Rheumatology|December 29, 2000
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature reviewI N Bruce, C A Clark-Soloninka, K A Spitzer, et al.
The Quarterly Journal of Medicine|January 1, 1977
Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosisP Lee, M B Urowitz, A A Bookman, et al.
Arthritis and Rheumatism|May 1, 1976
Mixed leukocyte reaction in rheumatoid arthritisE C Keystone, D D Gladman, M B Urowitz, et al.
The Journal of Rheumatology|February 1, 1994
Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activityW Pruzanski, N J Goulding, R J Flower, et al.
The Journal of Rheumatology|October 19, 2000
Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosusD D Gladman, M B Urowitz, D Slonim, et al.
The Journal of Rheumatology|August 1, 1994
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validationD D Gladman, C H Goldsmith, M B Urowitz, et al.
The Journal of Rheumatology|April 1, 1992
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosusD D Gladman, C H Goldsmith, M B Urowitz, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyD A Isenberg, M Petri, K Kalunian, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Rheumatology. Supplement|January 1, 1977
HLA antigens in osteitis condensans ilii and ankylosing spondylitisD P Singal, P de Bosset, D A Gordon, et al.
Clinical and Experimental Rheumatology|July 28, 2010
Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosusZ Touma, D D Gladman, D Tulloch-Reid, et al.
The Journal of Rheumatology|December 29, 2000
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature reviewI N Bruce, C A Clark-Soloninka, K A Spitzer, et al.
The Quarterly Journal of Medicine|January 1, 1977
Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosisP Lee, M B Urowitz, A A Bookman, et al.
Arthritis and Rheumatism|May 1, 1976
Mixed leukocyte reaction in rheumatoid arthritisE C Keystone, D D Gladman, M B Urowitz, et al.
The Journal of Rheumatology|February 1, 1994
Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activityW Pruzanski, N J Goulding, R J Flower, et al.
The Journal of Rheumatology|October 19, 2000
Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosusD D Gladman, M B Urowitz, D Slonim, et al.
The Journal of Rheumatology|August 1, 1994
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validationD D Gladman, C H Goldsmith, M B Urowitz, et al.
The Journal of Rheumatology|April 1, 1992
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosusD D Gladman, C H Goldsmith, M B Urowitz, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyD A Isenberg, M Petri, K Kalunian, et al.
Pageof 22